Story thread · 3 reports / 2 sources
Ascendis Pharma authorizes $400 million share buyback program
investing.com · 13h · first report
The coverage
- Ascendis Pharma sets $400M stock buyback plan
seekingalpha.com · 3h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.